US9181187, Compound J

ID: ALA3967376

Chembl Id: CHEMBL3967376

PubChem CID: 58891900

Max Phase: Preclinical

Molecular Formula: C23H25ClN6O3S2

Molecular Weight: 533.08

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1csc(S(=O)(=O)N(c2cc(C)c(Cl)cc2OCc2ccc(-c3nnn[nH]3)cc2C)C(C)C)n1

Standard InChI:  InChI=1S/C23H25ClN6O3S2/c1-13(2)30(35(31,32)23-25-16(5)12-34-23)20-9-15(4)19(24)10-21(20)33-11-18-7-6-17(8-14(18)3)22-26-28-29-27-22/h6-10,12-13H,11H2,1-5H3,(H,26,27,28,29)

Standard InChI Key:  JBZJCVZNZYZYDH-UHFFFAOYSA-N

Associated Targets(non-human)

Ptger1 Prostanoid EP1 receptor (301 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 533.08Molecular Weight (Monoisotopic): 532.1118AlogP: 5.08#Rotatable Bonds: 8
Polar Surface Area: 113.96Molecular Species: ACIDHBA: 8HBD: 1
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.30CX Basic pKa: CX LogP: 5.41CX LogD: 3.81
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.34Np Likeness Score: -1.79

References

1.  (2015)  Therapeutic agent for urinary excretion disorder, 

Source

Source(1):